Monoclonal antibody-BC2
Alternative Names: BC2Latest Information Update: 18 Jan 2008
At a glance
- Originator GlaxoSmithKline
- Class Antithrombotics; Monoclonal antibodies
- Mechanism of Action Factor IX inhibitors; Factor IXa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 23 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline
- 22 Mar 1999 Preclinical development for Thrombosis in USA (unspecified route)